Company Filing History:
Years Active: 2011-2014
Title: Innovations of Kate Nuwaysir
Introduction
Kate Nuwaysir is an accomplished inventor based in Madison, WI (US). She has made significant contributions to the field of oligonucleotide hybridization probes, with a focus on optimizing methods for both basic and clinical research. With a total of 2 patents, her work has the potential to enhance the accuracy and efficiency of genomic analysis.
Latest Patents
One of her latest patents is an optimized probe selection method. This invention provides methods for optimizing oligonucleotide hybridization probes for use in research. Specifically, it involves hybridizing serially diluted genomic samples to the oligonucleotide probes on an array. A signal intensity is produced for each of the probes, allowing for the computational identification of optimized probes. These optimized probes exhibit signal intensities that correspond to the serial dilutions of genomic samples and are reproducibly strong compared to non-optimized probes.
Career Highlights
Throughout her career, Kate has worked with notable companies such as Roche Nimblegen, Inc. and Ventana Medical Systems, Inc. Her experience in these organizations has contributed to her expertise in the field of genomic research and probe optimization.
Collaborations
Some of her coworkers include Todd Richmond and Jason Norton. Their collaboration has likely played a role in advancing the innovative work that Kate has accomplished.
Conclusion
Kate Nuwaysir's contributions to the field of oligonucleotide hybridization probes demonstrate her commitment to advancing genomic research. Her innovative methods and patents are paving the way for more effective research techniques in both basic and clinical settings.